{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:36:35Z","timestamp":1791412595968,"version":"4.3.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jos.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:37:26Z","timestamp":1750462646000},"page":"226-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors influencing the occurrence of drug-induced renal dysfunction during continuous local antibiotic perfusion therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-0402","authenticated-orcid":false,"given":"Yuki","family":"Fujihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Uchibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jos.2025.05.007_bib1","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jos.2023.12.001","article-title":"Treatment experience with continuous local antibiotic perfusion for periprosthetic joint infection","volume":"29","author":"Miyake","year":"2024","journal-title":"J Orthop Sci"},{"issue":"1","key":"10.1016\/j.jos.2025.05.007_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jos.2020.11.010","article-title":"A novel treatment strategy using continuous local antibiotic perfusion: a case series study of a refractory infection caused by hypervirulent Klebsiella pneumoniae","volume":"27","author":"Himeno","year":"2022","journal-title":"J Orthop Sci"},{"issue":"1","key":"10.1016\/j.jos.2025.05.007_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jos.2022.01.002","article-title":"Prosthetic joint infection after total talar replacement: an implant-retained case treated with combined continuous local antibiotic perfusion (CLAP)","volume":"29","author":"Iwamoto","year":"2024","journal-title":"J Orthop Sci"},{"issue":"4","key":"10.1016\/j.jos.2025.05.007_bib4","first-page":"1741","article-title":"Potential of continuous local antibiotic perfusion therapy for fracture-related infections","volume":"11","author":"Kosugi","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/23094990211051492","article-title":"Intra-medullary antibiotics perfusion (iMAP) for the control of fracture-related infection early after osteosynthesis","volume":"29","author":"Maruo","year":"2021","journal-title":"J Orthop Surg"},{"issue":"2","key":"10.1016\/j.jos.2025.05.007_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/10225536221111902","article-title":"Continuous local antibiotic perfusion: a treatment strategy that allows implant retention in fracture-related infections","volume":"30","author":"Maruo","year":"2022","journal-title":"J Orthop Surg"},{"key":"10.1016\/j.jos.2025.05.007_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jocn.2021.09.001","article-title":"Continuous local antibiotic perfusion for patients with surgical site infection after instrumented spinal surgery; a novel technique to retain the implants","volume":"93","author":"Takahashi","year":"2021","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.phrs.2010.04.004","article-title":"Gentamicin-induced nephrotoxicity: do we have a promising therapeutic approach to blunt it?","volume":"62","author":"Balakumar","year":"2010","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.jos.2025.05.007_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1470320308098343","article-title":"Experimental models for nephropathy","volume":"9","author":"Balakumar","year":"2008","journal-title":"J Renin-Angiotensin-Aldosterone Syst JRAAS"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0891-5849(03)00312-5","article-title":"Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage","volume":"35","author":"Maldonado","year":"2003","journal-title":"Free Radic Biol Med"},{"issue":"3\u20134","key":"10.1016\/j.jos.2025.05.007_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/08860229909085109","article-title":"Oxidant mechanisms in gentamicin nephrotoxicity","volume":"21","author":"Walker","year":"1999","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.jos.2025.05.007_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3346\/jkms.2006.21.5.904","article-title":"Increased expression of heat shock protein 72 protects renal proximal tubular cells from gentamicin-induced injury","volume":"21","author":"Wang","year":"2006","journal-title":"J Kor Med Sci"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1\u20133","key":"10.1016\/j.jos.2025.05.007_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2010.03.002","article-title":"The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy","volume":"636","author":"Arora","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrs.2009.01.010","article-title":"Emerging role of PPAR ligands in the management of diabetic nephropathy","volume":"60","author":"Balakumar","year":"2009","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.jos.2025.05.007_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01480540902976911","article-title":"Halofuginone has a beneficial effect on gentamicin-induced acute nephrotoxicity in rats","volume":"32","author":"Karakoyun","year":"2009","journal-title":"Drug Chem Toxicol"},{"issue":"4","key":"10.1016\/j.jos.2025.05.007_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.phrs.2008.12.009","article-title":"Protective effect of green tea extract on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney","volume":"59","author":"Khan","year":"2009","journal-title":"Pharmacol Res"},{"issue":"10","key":"10.1016\/j.jos.2025.05.007_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.jos.2025.05.007_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/08860220902835863","article-title":"Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways","volume":"31","author":"Ozbek","year":"2009","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11255-009-9645-7","article-title":"Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats","volume":"42","author":"Ozbek","year":"2010","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.jos.2025.05.007_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ptr.2861","article-title":"Protective effect of oleanolic acid on gentamicin induced nephrotoxicity in rats","volume":"24","author":"Patil","year":"2010","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.jos.2025.05.007_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/08860220802546321","article-title":"Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats","volume":"31","author":"Stojiljkovic","year":"2009","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.jos.2025.05.007_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ndt\/gfn545","article-title":"Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells","volume":"24","author":"Sue","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.jos.2025.05.007_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/j.1875-9114.1997.tb03760.x","article-title":"Pharmacoeconomic impact of once-daily aminoglycoside administration","volume":"17","author":"Hitt","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jos.2025.05.007_bib26","series-title":"Sanford guide to antimicrobial therapy","year":"2023"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265825001769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265825001769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:40:02Z","timestamp":1768063202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265825001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0949265825001769"],"URL":"https:\/\/doi.org\/10.1016\/j.jos.2025.05.007","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors influencing the occurrence of drug-induced renal dysfunction during continuous local antibiotic perfusion therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jos.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}